NCT01516229View on ClinicalTrials.gov

Special Survey for Long Term Application

CompletedOBSERVATIONAL

Enrollment

395

Participants

Timeline

Start Date

May 1, 1997

Primary Completion Date

March 31, 2007

Study Completion Date

March 31, 2007

Conditions

Genetic DisorderAchondroplasia

Interventions

DRUG

somatropin

Prescription of somatropin at the discretion of the physician

Trial Locations (2)

103

Novo Nordisk Investigational Site, Tokyo

1000005

Novo Nordisk Investigational Site, Tokyo

Sponsors

Lead Sponsor

Novo Nordisk A/S

All Listed Sponsors

lead

Novo Nordisk A/S

INDUSTRY

NCT01516229 - Special Survey for Long Term Application | Biotech Hunter | Biotech Hunter